| bibliographicCitation |
Gillman KW, Parker MF, Silva M, Degnan AP, Tora GO, Lodge NJ, Li Y, Lelas S, Taber M, Krause RG, Bertekap RL, Newton AE, Pieschl RL, Lengyel KD, Johnson KA, Taylor SJ, Bronson JJ, Macor JE. Design, optimization, and in vivo evaluation of a series of pyridine derivatives with dual NK1 antagonism and SERT inhibition for the treatment of depression. Bioorganic & Medicinal Chemistry Letters. 2013 Jan;23(2):407–11. doi: 10.1016/j.bmcl.2012.11.094. |